Skip to content
Home/Companies/Biotech/CALYSENS
CA

CALYSENS

Biotech·France·Active·5yr hold

CALYSENS is a healthcare company, headquartered in France.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns CALYSENS?

CALYSENS is currently owned by OBRATORI, L'Occitane Group Ventures through Obratori (2019 vintage), since 2021.

Hand-verified · updated 2026-04-21

OBRATORI, L'Occitane Group Ventures
Investor
OBRATORI, L'Occitane Group Ventures
Obratori · 2019 · VC

Key facts

HQFrance
SectorHealthcare

More from Obratori

Other portfolio companies in the same fund.

Humble +
Active
ConsumerFrance· 2024
Lazare Studio
Active
ConsumerFrance· 2024
Carton Vert
Active
ClimateTechFrance· 2023
KohortPay
Active
FintechFrance· 2023
Zeliq
Active
SaaSFrance· 2023
FunCell
Active
ClimateTechFrance· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings